A Phase II, Double-blind, Placebo Controlled, Randomized Study to Assess the Efficacy and Safety of 2 Doses of ZD6474 (Vandetanib) in Combination With FOLFOX vs FOLFOX Alone for the Treatment of Colorectal Cancer in Patients Who Have Failed Therapy With an Irinotecan and Fluoropyrimidine Regimen
收藏DataCite Commons2025-06-01 更新2026-05-07 收录
下载链接：
https://search.vivli.org/doiLanding/studies/PR00007704/isLanding
下载链接
链接失效反馈官方服务：
资源简介：
The purpose of this study is to determine whether treatment with ZACTIMA (vandetanib) in
combination with FOLFOX is more effective than FOLFOX alone for colorectal cancer in patients
who have failed therapy with an irinotecan and fluoropyrimidine containing regimen.
提供机构：
Vivli
创建时间：
2022-02-10
